On the fundamental side I loved these facts..
"revenue from Axiron of between US$7 million
and US$8 million in 2011/12 and approximately US$40 million in 2012/13. Acrux’s
operating expenditure is currently running at approximately $0.5 million per month"
$28Mil in the bank.
The first of the six potential net sales milestone payments is
expected to be received during the 2012/13 financial year.
"The board today reaffirmed its intention to declare the next dividend to shareholders
in August 2012"
I mean..wow what a great bio stock!
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.6¢ |
Change
-0.001(5.88%) |
Mkt cap ! $6.524M | |||
| Open | High | Low | Value | Volume |
| 1.7¢ | 1.7¢ | 1.5¢ | $19.90K | 1.210M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 463664 | 1.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.7¢ | 320000 | 2 |
View Market Depth
| Last trade - 15.56pm 25/06/2025 (20 minute delay) ? |
| ACR (ASX) Chart |